Table 2.
Factors of Interest | Number of Patients | Number of Events | HR 95% CI | P‐value |
---|---|---|---|---|
Absolute lymphocytes | 209 | 58 | 0.85 (.57, 1.26) | 0.41 |
Relative lymphocytes | 209 | 58 | 0.93 (.90, .97) | <0.001a |
Absolute eosinophils | 209 | 58 | 0.19 (.02, 2.39) | 0.20 |
Relative eosinophils | 209 | 58 | 0.73 (.59, .90) | 0.004a |
Absolute monocytes | 209 | 58 | 9.31 (4.07, 21.3) | <0.0001a |
Relative monocytes | 209 | 58 | 1.03 (.99, 1.07) | 0.21 |
Absolute neutrophils | 209 | 58 | 1.20 (1.13, 1.28) | <0.0001a |
Relative neutrophils | 209 | 58 | 1.06 (1.02, 1.09) | <0.001a |
Absolute basophils | 209 | 58 | 6.64 (.13, 342.8) | 0.35 |
Relative basophils | 209 | 58 | 0.34 (.15, .79) | 0.01a |
Neutrophil‐to‐lymphocyte ratio | 209 | 58 | 1.19 (1.12, 1.28) | <0.0001a |
indicates significant P‐value.